31/05/2025 - Immatics NV: Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma

[X]

The text version of this document is not available. You can access the original document here.

Disclaimer

Immatics NV published this content on May 31, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 31, 2025 at 12:04 UTC.

MoneyController also suggests